BREAKING NEWS IMPACTING MANUFACTURERS: The administration’s point-of-sale-rebate proposal is expected to be a final rule in the coming months. It focuses on Medicare and has a 2020 implementation date, excluding from safe harbor protection (under the Anti-Kickback Statute) rebates on drugs. Companies must rethink how they price, contract, distribute and position products within this changing marketplace. Key players within the drug distribution channel will offer ways to operationalize these sweeping changes, with chargebacks being a key mechanism at the pharmacy/point of sale. Join us in June to proactively prepare.

Celebrating its 15th year since inception, CBI’s Commercial Contract & Chargeback Excellence is a must-attend for pricing and contracting professionals. Join industry peers for incomparable networking opportunities and forward-thinking content from an array of expert stakeholders. This event offers interactive dialogue and best practices in a rapidly changing market to optimize contract decisions and management, improve chargeback adjudication processes, navigate class of trade complexities and streamline membership management.

Interactive Discussions and Benchmarking with Multi-Stakeholder Perspectives:

• Key trends and drivers of change impacting the commercial contracting landscape and market access
• New strategies for risk-share agreements and
  value-based contracting
• Optimize data exchange between trading partners
  from the wholesaler perspective
• GPO Best practices for streamlined membership management and accountability
• Valuable strategies for payer cost control approaches in the contracting space
• Impact of HHS Proposed Rule to eliminate prescription drug rebates on contracting stakeholders